This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
HSBC (HSBA.L) - HSBC, Europe's biggest bank, is weighing plans to spin off its British retail bank in a £20bn deal, the Sunday Times reported. Closing price 629.7p. (Reuters)
Barclays (BARC.L) - Barclays Plc failed to persuade a U.S. judge to dismiss a lawsuit accusing the British bank of defrauding shareholders about a private "dark pool" trading platform even as it was publicly pledging to clean up its corporate culture. Closing price 261.75p. (Reuters)
BP (BP.L) - Britain's outgoing government has told BP Plc that it wants the company to remain a British industrial champion and it would oppose any takeover of the oil producer, the Financial Times reported. Closing price 478.4p. (Reuters)
BHP Billiton (BLT.L) - BHP Billiton is contesting A$522m Australian tax bills on its Singapore marketing operations up to 2010, after having paid almost no tax in Singapore since 2006, the global miner told an Australian Senate panel. Closing price 1564p. (Reuters)
Tullow Oil (TLW.L) – Cleared to continue drilling projects. Development work on ten project continues. A tribunal has rejected Côte d'Ivoire's request that Ghana be ordered to suspend all oil exploration and exploitation in disputed zone including ten project. Closing price 418.00p. (Reuters/Digital Look)
Centrica (CNA.L) – The energy supplier, said its business was performing in line with guidance after a rise in gas and electricity consumption due to colder-than-average weather over Q1 in Britain and North America. Oil, gas exploration and production unit is on track to make savings of £100m by 2016. Closing price 264.50p (Reuters)
For more information on any of these individual news items, call into the trading floor
| Stock | Code | Close | High | Low |
| Reckitt Benckiser | RB.L | -0.17% | 2.15% | -0.95% |
| AstraZeneca | AZN.L | -1.67% | 1.04% | -3.44% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research